Excelsior Diagnostics Implements LabOS LIS

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

RIDGEFIELD PARK, New Jersey, July 22, 2019 /PRNewswire/ — Netlims, a global leader in laboratory information systems (LIS), announced that it has completed the implementation of its flagship LabOS product for Excelsior Diagnostics, a specialized genetics lab. Excelsior Diagnostics has chosen LabOS Core Labs and Genetics modules, as well as LabMD – which allows physicians to place lab orders and view results online. Apart from transforming Excelsior Diagnostics to a paperless lab, this implementation will support Excelsior’s promise for nationwide next day turnaround for tests.  

Netlims’ LabOS is a highly robust end-to-end web and cloud-based LIS platform; it provides an open API enabling integration with new systems and devices. All LabOS modules operate through a single database, using standard components and monitoring tools to support unlimited workloads with no single point of failure. Excelsior Diagnostics has chosen the LabOS SaaS model to benefit from a fully maintained and secure plug-and-play solution.

“Excelsior has chosen LabOS for its flexibility to support our cutting-edge molecular biology tests, and workflows with tens of targets in a single test,” said Jack Herskowitz, President and Founder of Excelsior Diagnostics. “LabOS supports the advanced services we offer, such as add-ons, ensuring quality of service for our customers.”

“These specialized genetic tests require the upmost precision and accuracy and we are honored to be Excelsior’s LIS of choice,” said Zvika Zisser, CEO, Netlims. “LabOS SaaS model enables the growth and connectivity necessary to lead the way in genetics testing.”

Excelsior Diagnostics

Excelsior Diagnostics is a leader in molecular microbiology, with unprecedented accuracy, specificity, and nationwide next day turnaround service. Excelsior’s laboratories eliminate broad-spectrum treatments and fight infectious diseases by using cutting edge technology to enable targeted care.

About Netlims

Netlims, part of the STMS Group, is a leading provider of Laboratory Information Systems, serving hundreds of hospitals and laboratories worldwide. Netlims’ success is based on thirty years of experience, heavy investment in R&D, and dedicated customer support.

 

Media Contact
Leo Borgenicht
Marketing, Netlims
Leo@netlims.com
Tel: +1(201)894-5300

 

View original content:http://www.prnewswire.com/news-releases/excelsior-diagnostics-implements-labos-lis-300888479.html

SOURCE Netlims

Staff

Recent Posts

Asgard Therapeutics appoints immunology expert Shane Olwill as Chief Development Officer

Pioneering cancer immunology company Asgard strengthens leadership team as it progresses its lead asset AT-108…

3 hours ago

Fangzhou Inc. Partners with Tencent Health and Tencent Cloud to Accelerate Development of AI-Enabled Healthcare Services

SHANGHAI, March 26, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader…

3 hours ago

Canadian Nurses Association Launches Bold Federal Election Platform to Strengthen Health Care

Ottawa, Ontario--(Newsfile Corp. - March 26, 2025) - The Canadian Nurses Association (CNA), representing Canada's…

4 hours ago

Defence Announces US Molecular and Antibody Research Expert Dr. Elias Theodorou Joins Defence’s Management Team as Chief Operating Officer

Montreal, Quebec--(Newsfile Corp. - March 26, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF)…

5 hours ago

Solventum partners with SprintRay to disrupt the digital dentistry market with high-quality, permanent same-day restorations

In this first-of-its-kind partnership for its Dental Solutions business, Solventum, formerly 3M Health Care, is…

9 hours ago

Health in Tech Expands Access to Virtual Care Through Collaboration with DialCare

STUART, Fla., March 25, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform…

15 hours ago